ACSL4 and neoplasm: ACSL4, long chain acyl-CoA synthetase, has been shown to be able to stabilize c-Myc expression and promote tumour cell proliferation and tumour progression in HCC, and patients with high expression of ACSL4 have poorer RFS [41].